High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
by from Morbidity and Mortality Weekly Report (MMWR) on (#2VXT7)
External Content
| Source | RSS or Atom Feed |
| Feed Location | http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5 |
| Feed Title | Morbidity and Mortality Weekly Report (MMWR) |
| Feed Link | https://www.cdc.gov/mmwr/index.html |
| Reply | 0 comments |